ey0021.8-12 | Clinical Trials – New Treatments | ESPEYB21
G Russell
, K Kalafatakis
, C Durant
, N Marchant
, J Thakrar
, R Thirard
, J King
, J Bowles
, T Upton
, NJ Thai
, JCW Brooks
, A Wilson
, K Phillips
, S Ferguson
, M Grabski
, CA Rogers
, T Lampros
, S Wilson
, C Harmer
, M Munafo
, SL Lightman
Brief Summary: This 6-week randomized, crossover, double blind, placebo-controlled feasibility trial assessed the effect of subcutaneous pump hydrocortisone on the quality of life, mood, functional neuroimaging, behavioral/cognitive responses, sleep and metabolism in adults with primary adrenal insufficiency (PAI) compared to standard therapy.Comment: Adrenal glucocorticoid secretion is characterized by a complex diurnal variation, formed by changes in p...